Attaining optimal asthma control: A practice parameter

被引:80
作者
Li, JT [1 ]
Oppenheimer, J [1 ]
Bernstein, IL [1 ]
Nicklas, RA [1 ]
机构
[1] Joint Council Allergy Asthma & Immunol, Palatine, IL 60067 USA
关键词
D O I
10.1016/j.jaci.2005.08.017
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the Amercian College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy. Asthma and Immunology (AAAAl) and the American College of Allergy, Asthma and Immunology (ACAAl) have jointly accepted responsibility for establishing "Attaining optimal asthma control: A practice parameter. " This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or the ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAl, and the Joint Council of Allergy. Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.
引用
收藏
页码:S3 / S11
页数:9
相关论文
共 50 条
[1]   Achieving guideline-based asthma control: does the patient benefit? [J].
Bateman, ED ;
Frith, LF ;
Braunstein, GL .
EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (03) :588-595
[2]   Can guideline-defined asthma control be achieved? The gaining optimal asthma control study [J].
Bateman, ED ;
Boushey, HA ;
Bousquet, J ;
Busse, WW ;
Clark, TJH ;
Pauwels, RA ;
Pedersen, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :836-844
[3]   Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone [J].
Baumgartner, RA ;
Martinez, G ;
Edelman, JM ;
Gomez, GGR ;
Bernstein, M ;
Bird, S ;
Angner, R ;
Polis, A ;
Dass, SB ;
Lu, S ;
Reiss, TF .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (01) :123-128
[4]  
Boulet Louis-Philippe, 2002, Can Respir J, V9, P417
[5]   Asthma variability in patients previously treated with β2-agonists alone [J].
Calhoun, WJ ;
Sutton, LB ;
Emmett, A ;
Dorinsky, PM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (06) :1088-1094
[6]   Asthma control versus asthma severity [J].
Cockcroft, DW ;
Swystun, VA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) :1016-1018
[7]   Assessment of variations in control of asthma over time [J].
Combescure, C ;
Chanez, P ;
Saint-Pierre, P ;
Daurès, JP ;
Proudhon, H ;
Godard, P .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) :298-304
[8]   Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma [J].
Covar, RA ;
Szefler, SJ ;
Martin, RJ ;
Sundstrom, DA ;
Silkoff, PE ;
Murphy, J ;
Young, DA ;
Spahn, JD .
JOURNAL OF PEDIATRICS, 2003, 142 (05) :469-475
[9]  
Delgado-Corcoran Claudia, 2004, Pediatr Crit Care Med, V5, P48, DOI 10.1097/01.CCM.0000105310.00799.51
[10]  
Ducharme Francine M, 2004, Can Respir J, V11, P541